Hepatic, Cardiovascular, and Endocrine Outcomes of the Histological Subphenotypes of Nonalcoholic Fatty Liver Disease
The DOI matches its Crossref record.
Abstract
This review covers the diagnosis and outcomes of histological subphenotypes of nonalcoholic fatty liver disease (NAFLD) including nonalcoholic steatohepatitis (NASH) in both children and adults. Serious outcomes of NAFLD include cirrhosis, hepatocellular carcinoma, coronary heart disease, and diabetes. The ability to determine differential outcomes by NAFLD subtypes is dependent upon both the adequate assessment of histological subtypes, as well as the appropriate measure of the outcome of interest. Steatohepatitis, which can only be diagnosed by liver biopsy, has a greater risk for both hepatic and systemic complications than simple steatosis. Differences in subphenotypes between children and adults and among children have only recently been described. Careful future attention should be given to determine their influence on clinical outcomes. Enhanced understanding of the epidemiology of NAFLD subphenotypes may help organize collaborative efforts between hepatologists, pathologists, cardiologists, endocrinologists, and primary care physicians to develop clinical management protocols.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cited by
Lack of Exercise Is a Major Cause of Chronic Diseases
Booth, F. W., Roberts, C. K., & Laye, M. J. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110025 · Cited by 2,575
Williams, C. D., Stengel, J., Asike, M. I., Torres, D. M., Shaw, J., Contreras, M., Landt, C. L., & Harrison, S. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,148
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
Reeder, S. B., Cruite, I., Hamilton, G., & Sirlin, C. B. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22580 · Cited by 822
“Hepatic steatosis is the histological hallmark of NAFLD and is accepted by most investigators to play a pathogenic role in the development of nonalcoholic steatohepatitis (NASH), a more aggressive subset of NAFLD, characterized by necroinflammation, fibrosis, and, eventually, cirrhosis (8,15–17).”
BackgroundInfluentialLoomba, R., Wolfson, T., Ang, B., Hooker, J., Behling, C., Peterson, M., Valasek, M., Lin, G., Brenner, D., Gamst, A., et al. (2014) · Hepatology · doi:10.1002/hep.27362 · Cited by 489
Meisamy, S., Hines, C. D. G., Hamilton, G., Sirlin, C. B., McKenzie, C. A., Yu, H., Brittain, J. H., & Reeder, S. B. (2011) · Radiology · doi:10.1148/radiol.10100708 · Cited by 382
Metadata
- Authors
- Rubinstein, E., Lavine, J., & Schwimmer, J.
- Affiliations
- University of California San Diego (US)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2008-10-27
- Volume
- 28
- Issue
- 04
- Pages
- 380-385
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2043067047
- Cited by
- 60
- References
- 0
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 2 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 4
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, liver biopsy, liver cirrhosis, hepatocellular carcinoma, coronary artery disease, diabetes mellitus, pediatric NAFLD, clinical outcomes
- MeSH terms
- Diabetes Mellitus, Fatty Liver, Carcinoma, Hepatocellular, Humans, Hypothalamic Diseases, Liver Cirrhosis, Liver Neoplasms, Comorbidity, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatic, Cardiovascular, and Endocrine Outcomes of the Histological Subphenotypes of Nonalcoholic Fatty Liver Disease. https://app.cochat.ai/papers/10.1055/s-0028-1091982
- The paper
- Rubinstein, E., Lavine, J., & Schwimmer, J. (2008). Hepatic, Cardiovascular, and Endocrine Outcomes of the Histological Subphenotypes of Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease. https://doi.org/10.1055/s-0028-1091982
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.